Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
reg-snw-4800 | wolf-screen-ratio-mammosphere-adherent | 0.833 | 7.78e-07 | 2.65e-03 | 5.08e-03 | 7 | 5 |
int-snw-9527 | wolf-screen-ratio-mammosphere-adherent | 0.934 | 1.77e-15 | 2.52e-03 | 4.06e-02 | 10 | 9 |
reg-snw-2547 | wolf-screen-ratio-mammosphere-adherent | 0.862 | 2.49e-07 | 1.43e-03 | 2.94e-03 | 5 | 4 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | Transcription factor | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|---|
COPA | 1314 | 7 | 0.434 | 0.833 | 170 | TF | Yes | - |
RPL8 | 6132 | 24 | 0.778 | 0.874 | 234 | TF | Yes | - |
HNRNPC | 3183 | 108 | 1.812 | 0.973 | 181 | - | Yes | - |
TP53 | 7157 | 23 | 0.432 | 0.833 | 665 | TF | - | - |
RPL6 | 6128 | 37 | 0.844 | 1.113 | 164 | - | Yes | - |
TUBA1C | 84790 | 5 | 0.966 | 0.993 | 91 | - | Yes | - |
GOSR1 | 9527 | 3 | -0.022 | 0.934 | 176 | - | - | - |
RPL11 | 6135 | 21 | 0.718 | 1.017 | 200 | - | Yes | - |
NFYA | 4800 | 7 | 0.198 | 0.833 | 80 | TF | - | - |
CCNA2 | 890 | 54 | 0.550 | 0.973 | 246 | TF | Yes | - |
CLTC | 1213 | 56 | 0.884 | 1.138 | 247 | - | Yes | - |
XRCC6 | 2547 | 2 | 0.031 | 0.862 | 63 | TF | - | - |
RPL14 | 9045 | 49 | 1.250 | 1.113 | 166 | - | Yes | - |
ACTB | 60 | 134 | 1.153 | 1.151 | 610 | - | Yes | - |
POLR2H | 5437 | 2 | 0.775 | 0.862 | 14 | - | Yes | - |
HSPD1 | 3329 | 70 | 0.913 | 1.035 | 325 | - | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
ACTB | 60 | RPL11 | 6135 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ACTB | 60 | CLTC | 1213 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | HSPD1 | 3329 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, YeastLow |
RPL14 | 9045 | GOSR1 | 9527 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
ACTB | 60 | NFYA | 4800 | pd | < | reg.pazar.txt: no annot; reg.oreganno.txt: no annot |
ACTB | 60 | GOSR1 | 9527 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
XRCC6 | 2547 | RPL8 | 6132 | pd | <> | reg.ITFP.txt: no annot |
RPL8 | 6132 | GOSR1 | 9527 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
COPA | 1314 | RPL11 | 6135 | pp | -- | int.I2D: BioGrid_Yeast |
RPL6 | 6128 | GOSR1 | 9527 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
XRCC6 | 2547 | HSPD1 | 3329 | pd | > | reg.ITFP.txt: no annot |
RPL11 | 6135 | GOSR1 | 9527 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
HNRNPC | 3183 | GOSR1 | 9527 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPL8 | 6132 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
RPL8 | 6132 | RPL11 | 6135 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium, IntAct_Yeast |
XRCC6 | 2547 | TP53 | 7157 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, BIND, HPRD, IntAct, BCI; int.Ravasi: -; int.HPRD: in vivo |
HNRNPC | 3183 | TP53 | 7157 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | COPA | 1314 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | COPA | 1314 | pp | -- | int.I2D: BioGrid_Yeast |
RPL11 | 6135 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
CLTC | 1213 | GOSR1 | 9527 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
XRCC6 | 2547 | POLR2H | 5437 | pd | > | reg.ITFP.txt: no annot |
XRCC6 | 2547 | HNRNPC | 3183 | pd | > | reg.ITFP.txt: no annot |
RPL6 | 6128 | RPL8 | 6132 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
COPA | 1314 | RPL14 | 9045 | pd | > | reg.ITFP.txt: no annot |
NFYA | 4800 | TP53 | 7157 | pd | > | reg.pazar.txt: no annot |
NFYA | 4800 | TP53 | 7157 | pp | -- | int.Intact: MI:0914(association), MI:0915(physical association), MI:0403(colocalization); int.I2D: BioGrid, HPRD, IntAct, BCI; int.Ravasi: -; int.HPRD: in vivo |
HSPD1 | 3329 | TP53 | 7157 | pp | -- | int.Intact: MI:0914(association) |
ACTB | 60 | RPL6 | 6128 | pp | -- | int.I2D: BioGrid_Yeast |
CCNA2 | 890 | TP53 | 7157 | pp | -- | int.I2D: HPRD, BCI, BioGrid; int.HPRD: in vitro |
CLTC | 1213 | XRCC6 | 2547 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: HPRD, IntAct, BIND, MINT; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
RPL6 | 6128 | RPL11 | 6135 | pp | -- | int.I2D: BioGrid_Yeast |
RPL11 | 6135 | TP53 | 7157 | pp | -- | int.I2D: BioGrid |
CCNA2 | 890 | NFYA | 4800 | pd | < | reg.TRANSFAC.txt: no annot |
GOSR1 | 9527 | TUBA1C | 84790 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
HSPD1 | 3329 | GOSR1 | 9527 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPL6 | 6128 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | NFYA | 4800 | pd | > | reg.ITFP.txt: no annot |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0016032 | viral process | 1.39e-08 | 2.27e-04 | 3.918 | 8 | 55 | 540 |
GO:0016020 | membrane | 5.34e-08 | 8.72e-04 | 2.684 | 11 | 80 | 1746 |
GO:0022625 | cytosolic large ribosomal subunit | 1.27e-07 | 2.07e-03 | 6.380 | 4 | 5 | 49 |
GO:0005829 | cytosol | 2.14e-07 | 3.49e-03 | 2.256 | 12 | 125 | 2562 |
GO:0019083 | viral transcription | 9.79e-07 | 1.60e-02 | 5.655 | 4 | 8 | 81 |
GO:0006415 | translational termination | 1.31e-06 | 2.13e-02 | 5.551 | 4 | 8 | 87 |
GO:0006414 | translational elongation | 1.71e-06 | 2.78e-02 | 5.455 | 4 | 11 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 2.67e-06 | 4.36e-02 | 5.294 | 4 | 8 | 104 |
GO:0044822 | poly(A) RNA binding | 2.82e-06 | 4.60e-02 | 2.920 | 8 | 50 | 1078 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 3.85e-06 | 6.29e-02 | 5.162 | 4 | 10 | 114 |
GO:0019058 | viral life cycle | 3.99e-06 | 6.51e-02 | 5.149 | 4 | 10 | 115 |
GO:0044267 | cellular protein metabolic process | 4.67e-06 | 7.62e-02 | 3.628 | 6 | 24 | 495 |
GO:0006413 | translational initiation | 6.69e-06 | 1.09e-01 | 4.961 | 4 | 12 | 131 |
GO:0043234 | protein complex | 7.51e-06 | 1.23e-01 | 4.088 | 5 | 17 | 300 |
GO:0003735 | structural constituent of ribosome | 8.96e-06 | 1.46e-01 | 4.855 | 4 | 8 | 141 |
GO:0003723 | RNA binding | 1.70e-05 | 2.77e-01 | 3.845 | 5 | 19 | 355 |
GO:0010467 | gene expression | 2.61e-05 | 4.26e-01 | 3.194 | 6 | 58 | 669 |
GO:0005654 | nucleoplasm | 4.01e-05 | 6.55e-01 | 2.705 | 7 | 83 | 1095 |
GO:0016071 | mRNA metabolic process | 5.43e-05 | 8.86e-01 | 4.194 | 4 | 34 | 223 |
GO:0006412 | translation | 6.66e-05 | 1.00e+00 | 4.118 | 4 | 15 | 235 |
GO:0042273 | ribosomal large subunit biogenesis | 6.98e-05 | 1.00e+00 | 7.294 | 2 | 4 | 13 |
GO:0016070 | RNA metabolic process | 8.07e-05 | 1.00e+00 | 4.046 | 4 | 34 | 247 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.06e-04 | 1.00e+00 | 6.535 | 2 | 4 | 22 |
GO:0019901 | protein kinase binding | 2.19e-04 | 1.00e+00 | 3.673 | 4 | 21 | 320 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.25e-04 | 1.00e+00 | 6.471 | 2 | 4 | 23 |
GO:0000790 | nuclear chromatin | 2.74e-04 | 1.00e+00 | 4.524 | 3 | 7 | 133 |
GO:0019843 | rRNA binding | 3.12e-04 | 1.00e+00 | 6.240 | 2 | 3 | 27 |
GO:0031492 | nucleosomal DNA binding | 3.36e-04 | 1.00e+00 | 6.187 | 2 | 4 | 28 |
GO:0061024 | membrane organization | 3.61e-04 | 1.00e+00 | 4.390 | 3 | 5 | 146 |
GO:0005925 | focal adhesion | 3.81e-04 | 1.00e+00 | 3.463 | 4 | 18 | 370 |
GO:0005198 | structural molecule activity | 4.63e-04 | 1.00e+00 | 4.267 | 3 | 4 | 159 |
GO:0051084 | 'de novo' posttranslational protein folding | 5.88e-04 | 1.00e+00 | 5.785 | 2 | 4 | 37 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 9.80e-04 | 1.00e+00 | 9.994 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 9.80e-04 | 1.00e+00 | 9.994 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 9.80e-04 | 1.00e+00 | 9.994 | 1 | 1 | 1 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.07e-03 | 1.00e+00 | 3.067 | 4 | 17 | 487 |
GO:0003684 | damaged DNA binding | 1.12e-03 | 1.00e+00 | 5.322 | 2 | 11 | 51 |
GO:0003725 | double-stranded RNA binding | 1.25e-03 | 1.00e+00 | 5.240 | 2 | 6 | 54 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 1.25e-03 | 1.00e+00 | 5.240 | 2 | 5 | 54 |
GO:0002039 | p53 binding | 1.30e-03 | 1.00e+00 | 5.213 | 2 | 7 | 55 |
GO:0051087 | chaperone binding | 1.49e-03 | 1.00e+00 | 5.112 | 2 | 6 | 59 |
GO:0032481 | positive regulation of type I interferon production | 1.59e-03 | 1.00e+00 | 5.064 | 2 | 6 | 61 |
GO:0006302 | double-strand break repair | 1.65e-03 | 1.00e+00 | 5.040 | 2 | 8 | 62 |
GO:0097252 | oligodendrocyte apoptotic process | 1.96e-03 | 1.00e+00 | 8.994 | 1 | 1 | 2 |
GO:1901525 | negative regulation of macromitophagy | 1.96e-03 | 1.00e+00 | 8.994 | 1 | 1 | 2 |
GO:0043564 | Ku70:Ku80 complex | 1.96e-03 | 1.00e+00 | 8.994 | 1 | 1 | 2 |
GO:0090343 | positive regulation of cell aging | 1.96e-03 | 1.00e+00 | 8.994 | 1 | 1 | 2 |
GO:0071475 | cellular hyperosmotic salinity response | 1.96e-03 | 1.00e+00 | 8.994 | 1 | 1 | 2 |
GO:0006289 | nucleotide-excision repair | 2.03e-03 | 1.00e+00 | 4.886 | 2 | 12 | 69 |
GO:0007265 | Ras protein signal transduction | 2.40e-03 | 1.00e+00 | 4.766 | 2 | 3 | 75 |
GO:0035794 | positive regulation of mitochondrial membrane permeability | 2.94e-03 | 1.00e+00 | 8.409 | 1 | 1 | 3 |
GO:0051097 | negative regulation of helicase activity | 2.94e-03 | 1.00e+00 | 8.409 | 1 | 1 | 3 |
GO:1900126 | negative regulation of hyaluronan biosynthetic process | 2.94e-03 | 1.00e+00 | 8.409 | 1 | 1 | 3 |
GO:0006458 | 'de novo' protein folding | 2.94e-03 | 1.00e+00 | 8.409 | 1 | 1 | 3 |
GO:0035033 | histone deacetylase regulator activity | 2.94e-03 | 1.00e+00 | 8.409 | 1 | 1 | 3 |
GO:0002360 | T cell lineage commitment | 2.94e-03 | 1.00e+00 | 8.409 | 1 | 1 | 3 |
GO:0034103 | regulation of tissue remodeling | 2.94e-03 | 1.00e+00 | 8.409 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 2.94e-03 | 1.00e+00 | 8.409 | 1 | 1 | 3 |
GO:0071439 | clathrin complex | 2.94e-03 | 1.00e+00 | 8.409 | 1 | 1 | 3 |
GO:0005200 | structural constituent of cytoskeleton | 3.66e-03 | 1.00e+00 | 4.455 | 2 | 7 | 93 |
GO:0001649 | osteoblast differentiation | 3.81e-03 | 1.00e+00 | 4.425 | 2 | 6 | 95 |
GO:0006364 | rRNA processing | 3.89e-03 | 1.00e+00 | 4.409 | 2 | 5 | 96 |
GO:0032051 | clathrin light chain binding | 3.92e-03 | 1.00e+00 | 7.994 | 1 | 1 | 4 |
GO:0090403 | oxidative stress-induced premature senescence | 3.92e-03 | 1.00e+00 | 7.994 | 1 | 1 | 4 |
GO:0002326 | B cell lineage commitment | 3.92e-03 | 1.00e+00 | 7.994 | 1 | 1 | 4 |
GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity | 3.92e-03 | 1.00e+00 | 7.994 | 1 | 2 | 4 |
GO:0016602 | CCAAT-binding factor complex | 3.92e-03 | 1.00e+00 | 7.994 | 1 | 1 | 4 |
GO:1903077 | negative regulation of protein localization to plasma membrane | 3.92e-03 | 1.00e+00 | 7.994 | 1 | 1 | 4 |
GO:0006266 | DNA ligation | 4.89e-03 | 1.00e+00 | 7.673 | 1 | 1 | 5 |
GO:0003691 | double-stranded telomeric DNA binding | 4.89e-03 | 1.00e+00 | 7.673 | 1 | 1 | 5 |
GO:0001940 | male pronucleus | 4.89e-03 | 1.00e+00 | 7.673 | 1 | 1 | 5 |
GO:0097371 | MDM2/MDM4 family protein binding | 4.89e-03 | 1.00e+00 | 7.673 | 1 | 1 | 5 |
GO:0071481 | cellular response to X-ray | 4.89e-03 | 1.00e+00 | 7.673 | 1 | 1 | 5 |
GO:0046696 | lipopolysaccharide receptor complex | 4.89e-03 | 1.00e+00 | 7.673 | 1 | 1 | 5 |
GO:0003688 | DNA replication origin binding | 5.87e-03 | 1.00e+00 | 7.409 | 1 | 1 | 6 |
GO:0010666 | positive regulation of cardiac muscle cell apoptotic process | 5.87e-03 | 1.00e+00 | 7.409 | 1 | 1 | 6 |
GO:0001221 | transcription cofactor binding | 5.87e-03 | 1.00e+00 | 7.409 | 1 | 1 | 6 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 5.87e-03 | 1.00e+00 | 7.409 | 1 | 1 | 6 |
GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process | 5.87e-03 | 1.00e+00 | 7.409 | 1 | 1 | 6 |
GO:0002309 | T cell proliferation involved in immune response | 5.87e-03 | 1.00e+00 | 7.409 | 1 | 1 | 6 |
GO:0030118 | clathrin coat | 5.87e-03 | 1.00e+00 | 7.409 | 1 | 1 | 6 |
GO:0070419 | nonhomologous end joining complex | 5.87e-03 | 1.00e+00 | 7.409 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 5.87e-03 | 1.00e+00 | 7.409 | 1 | 4 | 6 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 5.87e-03 | 1.00e+00 | 7.409 | 1 | 1 | 6 |
GO:0070245 | positive regulation of thymocyte apoptotic process | 5.87e-03 | 1.00e+00 | 7.409 | 1 | 1 | 6 |
GO:0007406 | negative regulation of neuroblast proliferation | 5.87e-03 | 1.00e+00 | 7.409 | 1 | 1 | 6 |
GO:0070062 | extracellular vesicular exosome | 6.49e-03 | 1.00e+00 | 1.505 | 7 | 98 | 2516 |
GO:0001939 | female pronucleus | 6.84e-03 | 1.00e+00 | 7.187 | 1 | 1 | 7 |
GO:0030157 | pancreatic juice secretion | 6.84e-03 | 1.00e+00 | 7.187 | 1 | 1 | 7 |
GO:0030132 | clathrin coat of coated pit | 6.84e-03 | 1.00e+00 | 7.187 | 1 | 1 | 7 |
GO:0031497 | chromatin assembly | 6.84e-03 | 1.00e+00 | 7.187 | 1 | 1 | 7 |
GO:0031982 | vesicle | 7.45e-03 | 1.00e+00 | 3.928 | 2 | 10 | 134 |
GO:0003677 | DNA binding | 7.77e-03 | 1.00e+00 | 1.917 | 5 | 26 | 1351 |
GO:0001055 | RNA polymerase II activity | 7.82e-03 | 1.00e+00 | 6.994 | 1 | 3 | 8 |
GO:0000733 | DNA strand renaturation | 7.82e-03 | 1.00e+00 | 6.994 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 7.82e-03 | 1.00e+00 | 6.994 | 1 | 1 | 8 |
GO:0075713 | establishment of integrated proviral latency | 7.82e-03 | 1.00e+00 | 6.994 | 1 | 2 | 8 |
GO:0000783 | nuclear telomere cap complex | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 1 | 9 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 2 | 9 |
GO:0031065 | positive regulation of histone deacetylation | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 1 | 9 |
GO:0033151 | V(D)J recombination | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 1 | 9 |
GO:0006457 | protein folding | 9.14e-03 | 1.00e+00 | 3.775 | 2 | 8 | 149 |
GO:0043032 | positive regulation of macrophage activation | 9.76e-03 | 1.00e+00 | 6.673 | 1 | 1 | 10 |
GO:0090399 | replicative senescence | 9.76e-03 | 1.00e+00 | 6.673 | 1 | 1 | 10 |
GO:2000648 | positive regulation of stem cell proliferation | 9.76e-03 | 1.00e+00 | 6.673 | 1 | 1 | 10 |
GO:0046902 | regulation of mitochondrial membrane permeability | 9.76e-03 | 1.00e+00 | 6.673 | 1 | 1 | 10 |
GO:0051604 | protein maturation | 9.76e-03 | 1.00e+00 | 6.673 | 1 | 1 | 10 |
GO:0032727 | positive regulation of interferon-alpha production | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 1 | 11 |
GO:0008340 | determination of adult lifespan | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 1 | 11 |
GO:0071850 | mitotic cell cycle arrest | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 1 | 11 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 3 | 11 |
GO:0001054 | RNA polymerase I activity | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 3 | 11 |
GO:0045120 | pronucleus | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 1 | 11 |
GO:0033762 | response to glucagon | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 1 | 11 |
GO:2000036 | regulation of stem cell maintenance | 1.07e-02 | 1.00e+00 | 6.535 | 1 | 2 | 11 |
GO:0000398 | mRNA splicing, via spliceosome | 1.11e-02 | 1.00e+00 | 3.628 | 2 | 12 | 165 |
GO:0005515 | protein binding | 1.13e-02 | 1.00e+00 | 0.873 | 11 | 172 | 6127 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.15e-02 | 1.00e+00 | 3.602 | 2 | 5 | 168 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.17e-02 | 1.00e+00 | 6.409 | 1 | 2 | 12 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.17e-02 | 1.00e+00 | 6.409 | 1 | 3 | 12 |
GO:0070266 | necroptotic process | 1.17e-02 | 1.00e+00 | 6.409 | 1 | 1 | 12 |
GO:0032461 | positive regulation of protein oligomerization | 1.17e-02 | 1.00e+00 | 6.409 | 1 | 1 | 12 |
GO:0009303 | rRNA transcription | 1.17e-02 | 1.00e+00 | 6.409 | 1 | 1 | 12 |
GO:0044212 | transcription regulatory region DNA binding | 1.19e-02 | 1.00e+00 | 3.577 | 2 | 6 | 171 |
GO:0006886 | intracellular protein transport | 1.22e-02 | 1.00e+00 | 3.560 | 2 | 4 | 173 |
GO:0048205 | COPI coating of Golgi vesicle | 1.27e-02 | 1.00e+00 | 6.294 | 1 | 1 | 13 |
GO:0001530 | lipopolysaccharide binding | 1.27e-02 | 1.00e+00 | 6.294 | 1 | 2 | 13 |
GO:0030126 | COPI vesicle coat | 1.27e-02 | 1.00e+00 | 6.294 | 1 | 1 | 13 |
GO:0008266 | poly(U) RNA binding | 1.27e-02 | 1.00e+00 | 6.294 | 1 | 1 | 13 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.27e-02 | 1.00e+00 | 6.294 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 4 | 14 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 2 | 14 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 14 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 14 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 14 |
GO:0007095 | mitotic G2 DNA damage checkpoint | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 14 |
GO:0009651 | response to salt stress | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 2 | 14 |
GO:0048568 | embryonic organ development | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 14 |
GO:0042026 | protein refolding | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 2 | 15 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.56e-02 | 1.00e+00 | 5.994 | 1 | 4 | 16 |
GO:0050998 | nitric-oxide synthase binding | 1.56e-02 | 1.00e+00 | 5.994 | 1 | 1 | 16 |
GO:0001056 | RNA polymerase III activity | 1.56e-02 | 1.00e+00 | 5.994 | 1 | 3 | 16 |
GO:0042149 | cellular response to glucose starvation | 1.65e-02 | 1.00e+00 | 5.907 | 1 | 1 | 17 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.65e-02 | 1.00e+00 | 5.907 | 1 | 3 | 17 |
GO:0050870 | positive regulation of T cell activation | 1.65e-02 | 1.00e+00 | 5.907 | 1 | 1 | 17 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.65e-02 | 1.00e+00 | 5.907 | 1 | 1 | 17 |
GO:0006386 | termination of RNA polymerase III transcription | 1.75e-02 | 1.00e+00 | 5.825 | 1 | 3 | 18 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.75e-02 | 1.00e+00 | 5.825 | 1 | 3 | 18 |
GO:0051721 | protein phosphatase 2A binding | 1.75e-02 | 1.00e+00 | 5.825 | 1 | 1 | 18 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 1.75e-02 | 1.00e+00 | 5.825 | 1 | 3 | 18 |
GO:0005657 | replication fork | 1.75e-02 | 1.00e+00 | 5.825 | 1 | 3 | 18 |
GO:0035035 | histone acetyltransferase binding | 1.85e-02 | 1.00e+00 | 5.747 | 1 | 1 | 19 |
GO:0071158 | positive regulation of cell cycle arrest | 1.85e-02 | 1.00e+00 | 5.747 | 1 | 1 | 19 |
GO:0032733 | positive regulation of interleukin-10 production | 1.85e-02 | 1.00e+00 | 5.747 | 1 | 1 | 19 |
GO:0010165 | response to X-ray | 1.85e-02 | 1.00e+00 | 5.747 | 1 | 2 | 19 |
GO:0050769 | positive regulation of neurogenesis | 1.85e-02 | 1.00e+00 | 5.747 | 1 | 1 | 19 |
GO:0002931 | response to ischemia | 1.94e-02 | 1.00e+00 | 5.673 | 1 | 1 | 20 |
GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 1.94e-02 | 1.00e+00 | 5.673 | 1 | 1 | 20 |
GO:0008156 | negative regulation of DNA replication | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 21 |
GO:0007369 | gastrulation | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 21 |
GO:0045087 | innate immune response | 2.08e-02 | 1.00e+00 | 2.313 | 3 | 20 | 616 |
GO:0007067 | mitotic nuclear division | 2.10e-02 | 1.00e+00 | 3.143 | 2 | 13 | 231 |
GO:0008380 | RNA splicing | 2.12e-02 | 1.00e+00 | 3.136 | 2 | 13 | 232 |
GO:0005759 | mitochondrial matrix | 2.13e-02 | 1.00e+00 | 3.130 | 2 | 12 | 233 |
GO:0005669 | transcription factor TFIID complex | 2.14e-02 | 1.00e+00 | 5.535 | 1 | 1 | 22 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 2.14e-02 | 1.00e+00 | 5.535 | 1 | 1 | 22 |
GO:0030863 | cortical cytoskeleton | 2.14e-02 | 1.00e+00 | 5.535 | 1 | 1 | 22 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 2.23e-02 | 1.00e+00 | 5.471 | 1 | 3 | 23 |
GO:0001836 | release of cytochrome c from mitochondria | 2.33e-02 | 1.00e+00 | 5.409 | 1 | 2 | 24 |
GO:0006363 | termination of RNA polymerase I transcription | 2.33e-02 | 1.00e+00 | 5.409 | 1 | 3 | 24 |
GO:0048147 | negative regulation of fibroblast proliferation | 2.33e-02 | 1.00e+00 | 5.409 | 1 | 1 | 24 |
GO:0005484 | SNAP receptor activity | 2.33e-02 | 1.00e+00 | 5.409 | 1 | 2 | 24 |
GO:0000060 | protein import into nucleus, translocation | 2.33e-02 | 1.00e+00 | 5.409 | 1 | 4 | 24 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 2.33e-02 | 1.00e+00 | 5.409 | 1 | 1 | 24 |
GO:0042100 | B cell proliferation | 2.42e-02 | 1.00e+00 | 5.351 | 1 | 1 | 25 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 2.42e-02 | 1.00e+00 | 5.351 | 1 | 1 | 25 |
GO:0007569 | cell aging | 2.42e-02 | 1.00e+00 | 5.351 | 1 | 2 | 25 |
GO:0071479 | cellular response to ionizing radiation | 2.42e-02 | 1.00e+00 | 5.351 | 1 | 1 | 25 |
GO:0042113 | B cell activation | 2.42e-02 | 1.00e+00 | 5.351 | 1 | 2 | 25 |
GO:0032735 | positive regulation of interleukin-12 production | 2.42e-02 | 1.00e+00 | 5.351 | 1 | 1 | 25 |
GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.52e-02 | 1.00e+00 | 5.294 | 1 | 3 | 26 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 2.52e-02 | 1.00e+00 | 5.294 | 1 | 3 | 26 |
GO:0004003 | ATP-dependent DNA helicase activity | 2.62e-02 | 1.00e+00 | 5.240 | 1 | 3 | 27 |
GO:0051258 | protein polymerization | 2.62e-02 | 1.00e+00 | 5.240 | 1 | 2 | 27 |
GO:0006281 | DNA repair | 2.69e-02 | 1.00e+00 | 2.950 | 2 | 22 | 264 |
GO:0001046 | core promoter sequence-specific DNA binding | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 28 |
GO:0007017 | microtubule-based process | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 3 | 28 |
GO:0019894 | kinesin binding | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 28 |
GO:0010332 | response to gamma radiation | 2.81e-02 | 1.00e+00 | 5.136 | 1 | 2 | 29 |
GO:0003730 | mRNA 3'-UTR binding | 2.81e-02 | 1.00e+00 | 5.136 | 1 | 2 | 29 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 2.81e-02 | 1.00e+00 | 5.136 | 1 | 1 | 29 |
GO:0043065 | positive regulation of apoptotic process | 2.89e-02 | 1.00e+00 | 2.896 | 2 | 8 | 274 |
GO:0006370 | 7-methylguanosine mRNA capping | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 4 | 30 |
GO:0051262 | protein tetramerization | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 3 | 30 |
GO:0034504 | protein localization to nucleus | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 2 | 30 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 4 | 30 |
GO:0021549 | cerebellum development | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 1 | 30 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 2 | 30 |
GO:0031623 | receptor internalization | 3.00e-02 | 1.00e+00 | 5.040 | 1 | 1 | 31 |
GO:0046677 | response to antibiotic | 3.00e-02 | 1.00e+00 | 5.040 | 1 | 2 | 31 |
GO:0016604 | nuclear body | 3.00e-02 | 1.00e+00 | 5.040 | 1 | 2 | 31 |
GO:0031201 | SNARE complex | 3.00e-02 | 1.00e+00 | 5.040 | 1 | 2 | 31 |
GO:0034644 | cellular response to UV | 3.09e-02 | 1.00e+00 | 4.994 | 1 | 5 | 32 |
GO:0033572 | transferrin transport | 3.09e-02 | 1.00e+00 | 4.994 | 1 | 6 | 32 |
GO:0030971 | receptor tyrosine kinase binding | 3.19e-02 | 1.00e+00 | 4.950 | 1 | 2 | 33 |
GO:0033077 | T cell differentiation in thymus | 3.19e-02 | 1.00e+00 | 4.950 | 1 | 2 | 33 |
GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 3.19e-02 | 1.00e+00 | 4.950 | 1 | 1 | 33 |
GO:0001085 | RNA polymerase II transcription factor binding | 3.28e-02 | 1.00e+00 | 4.907 | 1 | 2 | 34 |
GO:0005801 | cis-Golgi network | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 1 | 35 |
GO:0032588 | trans-Golgi network membrane | 3.47e-02 | 1.00e+00 | 4.825 | 1 | 1 | 36 |
GO:0034332 | adherens junction organization | 3.47e-02 | 1.00e+00 | 4.825 | 1 | 1 | 36 |
GO:0051402 | neuron apoptotic process | 3.47e-02 | 1.00e+00 | 4.825 | 1 | 2 | 36 |
GO:0001895 | retina homeostasis | 3.47e-02 | 1.00e+00 | 4.825 | 1 | 1 | 36 |
GO:0006605 | protein targeting | 3.47e-02 | 1.00e+00 | 4.825 | 1 | 2 | 36 |
GO:0032755 | positive regulation of interleukin-6 production | 3.47e-02 | 1.00e+00 | 4.825 | 1 | 2 | 36 |
GO:0001756 | somitogenesis | 3.66e-02 | 1.00e+00 | 4.747 | 1 | 1 | 38 |
GO:0070527 | platelet aggregation | 3.66e-02 | 1.00e+00 | 4.747 | 1 | 2 | 38 |
GO:0006383 | transcription from RNA polymerase III promoter | 3.76e-02 | 1.00e+00 | 4.709 | 1 | 3 | 39 |
GO:0006284 | base-excision repair | 3.76e-02 | 1.00e+00 | 4.709 | 1 | 7 | 39 |
GO:0032729 | positive regulation of interferon-gamma production | 3.76e-02 | 1.00e+00 | 4.709 | 1 | 2 | 39 |
GO:0005524 | ATP binding | 3.83e-02 | 1.00e+00 | 1.591 | 4 | 46 | 1354 |
GO:0001228 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 3.85e-02 | 1.00e+00 | 4.673 | 1 | 2 | 40 |
GO:0005881 | cytoplasmic microtubule | 3.95e-02 | 1.00e+00 | 4.637 | 1 | 2 | 41 |
GO:0042147 | retrograde transport, endosome to Golgi | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 3 | 42 |
GO:0032508 | DNA duplex unwinding | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 4 | 42 |
GO:0042110 | T cell activation | 4.14e-02 | 1.00e+00 | 4.568 | 1 | 3 | 43 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.22e-02 | 1.00e+00 | 1.916 | 3 | 19 | 811 |
GO:0048146 | positive regulation of fibroblast proliferation | 4.23e-02 | 1.00e+00 | 4.535 | 1 | 2 | 44 |
GO:0034613 | cellular protein localization | 4.23e-02 | 1.00e+00 | 4.535 | 1 | 1 | 44 |
GO:0006892 | post-Golgi vesicle-mediated transport | 4.23e-02 | 1.00e+00 | 4.535 | 1 | 2 | 44 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 4.23e-02 | 1.00e+00 | 4.535 | 1 | 2 | 44 |
GO:0050434 | positive regulation of viral transcription | 4.23e-02 | 1.00e+00 | 4.535 | 1 | 5 | 44 |
GO:0021762 | substantia nigra development | 4.42e-02 | 1.00e+00 | 4.471 | 1 | 1 | 46 |
GO:0030136 | clathrin-coated vesicle | 4.42e-02 | 1.00e+00 | 4.471 | 1 | 1 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 4.42e-02 | 1.00e+00 | 4.471 | 1 | 2 | 46 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 4.42e-02 | 1.00e+00 | 4.471 | 1 | 8 | 46 |
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 3 | 47 |
GO:0048511 | rhythmic process | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 2 | 47 |
GO:0005507 | copper ion binding | 4.61e-02 | 1.00e+00 | 4.409 | 1 | 2 | 48 |
GO:0031100 | organ regeneration | 4.79e-02 | 1.00e+00 | 4.351 | 1 | 4 | 50 |
GO:0035690 | cellular response to drug | 4.79e-02 | 1.00e+00 | 4.351 | 1 | 2 | 50 |
GO:0006986 | response to unfolded protein | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 2 | 51 |
GO:0005905 | coated pit | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 2 | 51 |
GO:0097193 | intrinsic apoptotic signaling pathway | 5.26e-02 | 1.00e+00 | 4.213 | 1 | 4 | 55 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 5.26e-02 | 1.00e+00 | 4.213 | 1 | 2 | 55 |
GO:0008104 | protein localization | 5.35e-02 | 1.00e+00 | 4.187 | 1 | 3 | 56 |
GO:0045216 | cell-cell junction organization | 5.63e-02 | 1.00e+00 | 4.112 | 1 | 2 | 59 |
GO:0000723 | telomere maintenance | 5.63e-02 | 1.00e+00 | 4.112 | 1 | 8 | 59 |
GO:0019903 | protein phosphatase binding | 6.00e-02 | 1.00e+00 | 4.017 | 1 | 4 | 63 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 6.10e-02 | 1.00e+00 | 3.994 | 1 | 1 | 64 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 6.19e-02 | 1.00e+00 | 3.972 | 1 | 22 | 65 |
GO:0045892 | negative regulation of transcription, DNA-templated | 6.36e-02 | 1.00e+00 | 2.267 | 2 | 14 | 424 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 6.37e-02 | 1.00e+00 | 3.928 | 1 | 6 | 67 |
GO:0030141 | secretory granule | 6.37e-02 | 1.00e+00 | 3.928 | 1 | 2 | 67 |
GO:0006366 | transcription from RNA polymerase II promoter | 6.38e-02 | 1.00e+00 | 2.263 | 2 | 12 | 425 |
GO:0003697 | single-stranded DNA binding | 6.56e-02 | 1.00e+00 | 3.886 | 1 | 9 | 69 |
GO:0043066 | negative regulation of apoptotic process | 6.60e-02 | 1.00e+00 | 2.236 | 2 | 30 | 433 |
GO:0035264 | multicellular organism growth | 6.65e-02 | 1.00e+00 | 3.865 | 1 | 1 | 70 |
GO:0034329 | cell junction assembly | 6.74e-02 | 1.00e+00 | 3.845 | 1 | 1 | 71 |
GO:0005634 | nucleus | 6.90e-02 | 1.00e+00 | 0.757 | 8 | 131 | 4828 |
GO:0032355 | response to estradiol | 6.92e-02 | 1.00e+00 | 3.805 | 1 | 5 | 73 |
GO:0000785 | chromatin | 6.92e-02 | 1.00e+00 | 3.805 | 1 | 5 | 73 |
GO:0002020 | protease binding | 7.02e-02 | 1.00e+00 | 3.785 | 1 | 4 | 74 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 7.11e-02 | 1.00e+00 | 3.766 | 1 | 1 | 75 |
GO:0005615 | extracellular space | 7.24e-02 | 1.00e+00 | 1.599 | 3 | 17 | 1010 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 7.29e-02 | 1.00e+00 | 3.728 | 1 | 5 | 77 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 7.29e-02 | 1.00e+00 | 3.728 | 1 | 6 | 77 |
GO:0007596 | blood coagulation | 7.44e-02 | 1.00e+00 | 2.136 | 2 | 14 | 464 |
GO:0071013 | catalytic step 2 spliceosome | 7.47e-02 | 1.00e+00 | 3.691 | 1 | 7 | 79 |
GO:0005730 | nucleolus | 7.50e-02 | 1.00e+00 | 1.277 | 4 | 70 | 1684 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 7.56e-02 | 1.00e+00 | 3.673 | 1 | 2 | 80 |
GO:0051301 | cell division | 7.66e-02 | 1.00e+00 | 3.655 | 1 | 6 | 81 |
GO:0005681 | spliceosomal complex | 7.84e-02 | 1.00e+00 | 3.619 | 1 | 3 | 83 |
GO:0005179 | hormone activity | 7.93e-02 | 1.00e+00 | 3.602 | 1 | 1 | 84 |
GO:0047485 | protein N-terminus binding | 8.11e-02 | 1.00e+00 | 3.568 | 1 | 4 | 86 |
GO:0006898 | receptor-mediated endocytosis | 8.11e-02 | 1.00e+00 | 3.568 | 1 | 2 | 86 |
GO:0042802 | identical protein binding | 8.21e-02 | 1.00e+00 | 2.055 | 2 | 18 | 491 |
GO:0050821 | protein stabilization | 8.56e-02 | 1.00e+00 | 3.487 | 1 | 2 | 91 |
GO:0003690 | double-stranded DNA binding | 8.56e-02 | 1.00e+00 | 3.487 | 1 | 4 | 91 |
GO:0016363 | nuclear matrix | 8.65e-02 | 1.00e+00 | 3.471 | 1 | 11 | 92 |
GO:0016605 | PML body | 8.65e-02 | 1.00e+00 | 3.471 | 1 | 5 | 92 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 8.65e-02 | 1.00e+00 | 3.471 | 1 | 4 | 92 |
GO:0042470 | melanosome | 8.65e-02 | 1.00e+00 | 3.471 | 1 | 10 | 92 |
GO:0006928 | cellular component movement | 8.65e-02 | 1.00e+00 | 3.471 | 1 | 7 | 92 |
GO:0051082 | unfolded protein binding | 8.92e-02 | 1.00e+00 | 3.425 | 1 | 6 | 95 |
GO:0006355 | regulation of transcription, DNA-templated | 8.94e-02 | 1.00e+00 | 1.471 | 3 | 17 | 1104 |
GO:0071456 | cellular response to hypoxia | 9.19e-02 | 1.00e+00 | 3.380 | 1 | 4 | 98 |
GO:0014069 | postsynaptic density | 9.90e-02 | 1.00e+00 | 3.267 | 1 | 1 | 106 |
GO:0006461 | protein complex assembly | 1.03e-01 | 1.00e+00 | 3.200 | 1 | 6 | 111 |
GO:0030308 | negative regulation of cell growth | 1.05e-01 | 1.00e+00 | 3.174 | 1 | 6 | 113 |
GO:0030529 | ribonucleoprotein complex | 1.06e-01 | 1.00e+00 | 3.162 | 1 | 8 | 114 |
GO:0005819 | spindle | 1.06e-01 | 1.00e+00 | 3.162 | 1 | 7 | 114 |
GO:0072562 | blood microparticle | 1.08e-01 | 1.00e+00 | 3.136 | 1 | 4 | 116 |
GO:0006325 | chromatin organization | 1.14e-01 | 1.00e+00 | 3.052 | 1 | 4 | 123 |
GO:0007219 | Notch signaling pathway | 1.16e-01 | 1.00e+00 | 3.029 | 1 | 4 | 125 |
GO:0007050 | cell cycle arrest | 1.17e-01 | 1.00e+00 | 3.017 | 1 | 7 | 126 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.20e-01 | 1.00e+00 | 2.972 | 1 | 3 | 130 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.26e-01 | 1.00e+00 | 2.896 | 1 | 7 | 137 |
GO:0044255 | cellular lipid metabolic process | 1.29e-01 | 1.00e+00 | 2.865 | 1 | 4 | 140 |
GO:0016887 | ATPase activity | 1.32e-01 | 1.00e+00 | 2.825 | 1 | 7 | 144 |
GO:0042981 | regulation of apoptotic process | 1.38e-01 | 1.00e+00 | 2.756 | 1 | 26 | 151 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.38e-01 | 1.00e+00 | 2.756 | 1 | 2 | 151 |
GO:0005769 | early endosome | 1.44e-01 | 1.00e+00 | 2.691 | 1 | 2 | 158 |
GO:0006974 | cellular response to DNA damage stimulus | 1.44e-01 | 1.00e+00 | 2.691 | 1 | 8 | 158 |
GO:0008022 | protein C-terminus binding | 1.47e-01 | 1.00e+00 | 2.664 | 1 | 4 | 161 |
GO:0007420 | brain development | 1.56e-01 | 1.00e+00 | 2.568 | 1 | 1 | 172 |
GO:0030424 | axon | 1.56e-01 | 1.00e+00 | 2.568 | 1 | 3 | 172 |
GO:0005667 | transcription factor complex | 1.61e-01 | 1.00e+00 | 2.519 | 1 | 6 | 178 |
GO:0031625 | ubiquitin protein ligase binding | 1.63e-01 | 1.00e+00 | 2.503 | 1 | 13 | 180 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.65e-01 | 1.00e+00 | 1.448 | 2 | 11 | 748 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.66e-01 | 1.00e+00 | 2.471 | 1 | 8 | 184 |
GO:0005737 | cytoplasm | 1.73e-01 | 1.00e+00 | 0.622 | 6 | 98 | 3976 |
GO:0003924 | GTPase activity | 1.82e-01 | 1.00e+00 | 2.329 | 1 | 9 | 203 |
GO:0001701 | in utero embryonic development | 1.87e-01 | 1.00e+00 | 2.280 | 1 | 6 | 210 |
GO:0006184 | GTP catabolic process | 1.95e-01 | 1.00e+00 | 2.213 | 1 | 9 | 220 |
GO:0008134 | transcription factor binding | 2.16e-01 | 1.00e+00 | 2.052 | 1 | 8 | 246 |
GO:0005874 | microtubule | 2.25e-01 | 1.00e+00 | 1.983 | 1 | 6 | 258 |
GO:0000166 | nucleotide binding | 2.36e-01 | 1.00e+00 | 1.907 | 1 | 6 | 272 |
GO:0019899 | enzyme binding | 2.48e-01 | 1.00e+00 | 1.825 | 1 | 11 | 288 |
GO:0005743 | mitochondrial inner membrane | 2.57e-01 | 1.00e+00 | 1.766 | 1 | 5 | 300 |
GO:0006200 | ATP catabolic process | 2.59e-01 | 1.00e+00 | 1.751 | 1 | 14 | 303 |
GO:0005856 | cytoskeleton | 2.65e-01 | 1.00e+00 | 1.714 | 1 | 8 | 311 |
GO:0005739 | mitochondrion | 2.74e-01 | 1.00e+00 | 0.964 | 2 | 24 | 1046 |
GO:0030154 | cell differentiation | 2.75e-01 | 1.00e+00 | 1.650 | 1 | 5 | 325 |
GO:0007411 | axon guidance | 2.77e-01 | 1.00e+00 | 1.641 | 1 | 9 | 327 |
GO:0005525 | GTP binding | 2.77e-01 | 1.00e+00 | 1.637 | 1 | 11 | 328 |
GO:0008283 | cell proliferation | 2.80e-01 | 1.00e+00 | 1.624 | 1 | 12 | 331 |
GO:0003682 | chromatin binding | 2.82e-01 | 1.00e+00 | 1.611 | 1 | 12 | 334 |
GO:0007275 | multicellular organismal development | 2.89e-01 | 1.00e+00 | 1.568 | 1 | 5 | 344 |
GO:0015031 | protein transport | 2.98e-01 | 1.00e+00 | 1.515 | 1 | 4 | 357 |
GO:0008285 | negative regulation of cell proliferation | 3.05e-01 | 1.00e+00 | 1.475 | 1 | 11 | 367 |
GO:0000278 | mitotic cell cycle | 3.26e-01 | 1.00e+00 | 1.358 | 1 | 52 | 398 |
GO:0046982 | protein heterodimerization activity | 3.27e-01 | 1.00e+00 | 1.354 | 1 | 11 | 399 |
GO:0000139 | Golgi membrane | 3.33e-01 | 1.00e+00 | 1.322 | 1 | 2 | 408 |
GO:0009986 | cell surface | 3.43e-01 | 1.00e+00 | 1.273 | 1 | 9 | 422 |
GO:0006915 | apoptotic process | 4.35e-01 | 1.00e+00 | 0.837 | 1 | 34 | 571 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.45e-01 | 1.00e+00 | 0.792 | 1 | 12 | 589 |
GO:0005783 | endoplasmic reticulum | 4.57e-01 | 1.00e+00 | 0.742 | 1 | 9 | 610 |
GO:0005794 | Golgi apparatus | 4.78e-01 | 1.00e+00 | 0.650 | 1 | 14 | 650 |
GO:0008270 | zinc ion binding | 6.61e-01 | 1.00e+00 | -0.065 | 1 | 12 | 1067 |
GO:0044281 | small molecule metabolic process | 7.34e-01 | 1.00e+00 | -0.344 | 1 | 57 | 1295 |
GO:0005886 | plasma membrane | 7.94e-01 | 1.00e+00 | -0.474 | 2 | 38 | 2834 |
GO:0006351 | transcription, DNA-templated | 8.05e-01 | 1.00e+00 | -0.636 | 1 | 25 | 1585 |
GO:0016021 | integral component of membrane | 9.29e-01 | 1.00e+00 | -1.283 | 1 | 15 | 2483 |